SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Cashflow Statement
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Cash Flow from Financing Activities | ₹199 Cr | ₹42 Cr | ₹617 Cr |
What is the latest Cash Flow from Financing Activities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹199 Cr |
| Mar2024 | ₹42 Cr |
| Mar2023 | ₹617 Cr |
How is Cash Flow from Financing Activities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹199 Cr | 369.89 | |
| Mar2024 | ₹42 Cr | -93.12 | |
| Mar2023 | ₹617 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹4,192.5 Cr | -3.3% | -0.1% | -7.2% | Stock Analytics | |
| SAGILITY INDIA | ₹20,977.0 Cr | -2.7% | -14.6% | -4.1% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹17,834.1 Cr | 1.8% | -25.3% | -36.5% | Stock Analytics | |
| LATENT VIEW ANALYTICS | ₹7,567.3 Cr | -5.3% | -9.8% | -4.7% | Stock Analytics | |
| JUST DIAL | ₹5,128.6 Cr | -6.2% | -12.3% | -22.4% | Stock Analytics | |
| AWFIS SPACE SOLUTIONS | ₹2,146.2 Cr | -7.5% | -27.1% | -52% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -3.3% |
-0.1% |
-7.2% |
| SENSEX | 0.2% |
1.1% |
8.8% |
You may also like the below Video Courses